Jane Street Group, LLC Synlogic, Inc. Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.56 - $1.07 $953 - $1,821	-1,702 Reduced 10.37%	14,709 $9,000
Q4 2022 Feb 14, 2023	BUY	$0.58 - $17.99 $9,518 - $295,233	16,411 New	16,411 $12,000
Q3 2021 Nov 16, 2021	SELL	$2.45 - $4.1 $36,115 - $60,438	-14,741 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.0 - $4.39 $44,223 - $64,712	14,741 New	14,741 $57,000
Q1 2021 May 18, 2021	SELL	$2.2 - $5.05 $40,216 - $92,314	-18,280 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$1.85 - $2.54 $11,179 - $15,349	-6,043 Reduced 24.84%	18,280 $39,000
Q3 2020 Nov 17, 2020	SELL	$1.85 - $2.57 $97,853 - $135,937	-52,894 Reduced 68.5%	24,323 $49,000
Q2 2020 Aug 17, 2020	BUY	$1.59 - $2.51 $122,775 - $193,814	77,217 New	77,217 $157,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.